• Trending
  • Latest
    Sign in Sign up

    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 0
      OpenAI goes for Microsoft’s jugular — its Office productivity suite - 9 minute(s) ago

      The ChatGPT maker is eyeing the launch of its own productivity suite with generative AI built in, directly attacking Microsoft’s multibillion dollar Microsoft 365 office suite business.

      Source: www.computerworld.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	EvanKirstel
        EvanKirstel

        The ChatGPT maker is eyeing the launch of its own productivity suite with generative AI built in, directly attacking Microsoft’s multibillion dollar Microsoft 365 office suite business Source: Computerworld https://t.co/xIiBgri6Xr

    • Mashup Score: 0
      Pulsed field ablation in persistent left superior vena cava for atrial fibrillation via interrupted inferior vena cava with azygos continuation utilizing novel electroanatomic mapping features in the presence of a permanent pacemaker - 9 minute(s) ago

      In 2004, Hsu and colleagues reported persistent left superior vena cava (PLSVC) as a potential source of atrial fibrillation (AF) triggers.1 Pulsed field ablation (PFA) is a non-thermal modality primarily developed to treat AF through pulmonary vein isolation.2 As the first commercial case was in 2021, there is limited experience on the use of PFA for potential non-pulmonary vein sources.2 In addition, the effect of direct contact between PFA and indwelling cardiac implantable electronic device (CIED) leads is largely unknown.

      Source: www.heartrhythmcasereports.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	HRS_CaseReports
        HRS_CaseReports

        Pulsed field ablation in persistent left superior vena cava for atrial fibrillation via interrupted inferior vena cava with azygos continuation utilizing novel electroanatomic mapping features in the presence of a permanent pacemaker @norman_c_wang https://t.co/Pu5s8UrxGm https://t.co/dukGbQ4ZxR

    • Mashup Score: 0
      Surgeons’ Contributions to Antibiotic Stewardship and Resistance Prevention - 24 minute(s) ago

      This survey study evaluates how surgeons in France understand their role in preventing antibiotic resistance.

      Source: jamanetwork.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	JAMANetworkOpen
        JAMANetworkOpen

        A survey of surgeons in France found that 48.7% perceive antibiotic resistance as a threat to surgical care, with many extending surgical antibiotic prophylaxis postoperatively. https://t.co/bQhIyNJIHQ https://t.co/04aYeWQrqq

    • Mashup Score: 0
      Imaging and pulmonary function techniques in ARDS diagnosis and management: current insights and challenges - Critical Care - 39 minute(s) ago

      Acute Respiratory Distress Syndrome (ARDS) is a life-threatening condition characterized by acute onset of respiratory failure, which presents significant challenges in diagnosis and management. Its heterogeneity, with diverse underlying aetiologies and variable patient responses to treatment, highlights the need for individualized care approaches. Accurate and timely diagnosis, coupled with personalized therapy, is essential to improving patient outcomes. In this context, the integration of advanced lung imaging techniques, such as chest computed tomography, lung ultrasound, and electrical impedance tomography, with functional parameters (like respiratory system compliance, driving pressure, transpulmonary pressure, and mechanical power) has emerged as a promising approach to enhance diagnostic precision. These imaging modalities provide valuable insights into the patient’s underlying respiratory mechanics and enable better assessment of disease severity. However, the clinical applica

      Source: ccforum.biomedcentral.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	BioMedCentral
        BioMedCentral

        A Review published in @Crit_Care examines how advanced lung imaging techniques combined with functional respiratory parameters, can improve the diagnosis and personalized management of ARDS. https://t.co/UlZFUBlf6O

    • Mashup Score: 2
      Mount Sinai Ranked a Global Leader in Health Care Research | Mount Sinai Today - 42 minute(s) ago

      In the Nature Index 2025 Research Leaders list released in June, the Mount Sinai Health System earned top marks: among health care institutions in the United States and North America, it was No. 5 for its research output. When compared against health care institutions around the world, Mount Sinai ranked sixth.

      Source: health.mountsinai.org
      Categories: General Medicine News, Neurology
      Tweet Tweets with this article
      • Profile photo of 	SinaiBrain
        SinaiBrain

        RT @EricJNestler: Mount Sinai ranked a global leader in healthcare research by the Nature index. @IcahnMountSinai https://t.co/ZTNBe1EebT

    • Mashup Score: 0
      Breaking Down What CAR T-Cell Therapy Means for Blood Cancers - 44 minute(s) ago

      Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of outpatient CAR T-cell therapy treatment.

      Source: www.curetoday.com
      Categories: General Medicine News, Nursing
      Tweet Tweets with this article
      • Profile photo of 	cure_today
        cure_today

        Breaking Down What CAR T-Cell Therapy Means for Blood Cancers @OlaOluwole4 @VUMChealth #BloodCancer #MedTwitter #Hematology https://t.co/S0JeRjvN8s

    • Mashup Score: 0
      Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial - 46 minute(s) ago

      Background Patients with diabetes mellitus (DM) have an elevated risk of late events after percutaneous coronary intervention (PCI). The Second-generation Drug-eluting Stents in Diabetes (SUGAR) trial ([NCT03321032][1]) compared amphilimus-eluting stents (AESs) and onyx-zotarolimus-eluting stents (O-ZESs) in this population. Objectives To report the co-primary endpoint comparing target lesion failure (TLF) between AES and O-ZES at 2 years and the extended follow-up at 3 years. Methods The SUGAR trial enrolled 1175 patients with DM across 23 centres in a randomised (1:1 AES (Cre8EVO) or O-ZES (Resolute Onyx)) assessor-blinded design. The primary endpoint, assessed with a Cox proportional hazards model, was TLF (a composite of cardiac death, target vessel myocardial infarction or ischaemia-driven target lesion revascularisation). Secondary endpoints included all-cause mortality, stent thrombosis and major adverse cardiac events. Results At 2 years, TLF occurred in 60 (10.4%) patients in

      Source: heart.bmj.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	Heart_BMJ
        Heart_BMJ

        Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial https://t.co/3kNjd0YNth https://t.co/aASxG3BuNK

    • Mashup Score: 0
      AstraZeneca Blockbuster Prospect Is a Bust in Pivotal Test in Light Chain Amyloidosis - MedCity News - 51 minute(s) ago

      Though anselamimab failed its Phase 3 test in light chain amyloidosis, AstraZeneca points to encouraging results in a pre-defined patient subgroup — which may not be a winning strategy. Prothena resurrected its failed drug candidate for the disease based on a subgroup analysis, only to see that antibody fall short in a pivotal study.

      Source: medcitynews.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	medcitynews
        medcitynews

        AstraZeneca Blockbuster Prospect Is a Bust in Pivotal Test in Light Chain Amyloidosis https://t.co/DMHoIxBwAZ

    • Mashup Score: 0
      ISHLT2026 Call for Abstract Reviewers - 55 minute(s) ago

      As ISHLT prepares for another exciting year of innovative research, interested members are invited to apply to serve as Abstract Reviewers for ISHLT2026. Complete the online application by Thursday, 31 July at 11:59 p.m. ET / Friday, 1 August at 3:59 UTC.

      Source: www.ishlt.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	ISHLT
        ISHLT

        Calling all #ISHLTMembers 📢 Apply to serve as an Abstract Reviewer for #ISHLT2026. This is a great opportunity to volunteer for the Society at any stage in your career. Learn more and apply at 🔗 https://t.co/ywjHyGnKNY 📖 https://t.co/blQGUL51Ud

    • Mashup Score: 0
      Imperative Care, Proximie partner to develop surgical robot to treat stroke - 1 hour(s) ago

      Proximie and Imperative Care today announced a partnership aimed at driving the development of a surgical robot to treat ischemic stroke.

      Source: www.massdevice.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	Sid_Healthcare
        Sid_Healthcare

        Imperative Care @ImpCare_Stroke @Proximie partner to develop surgical robot to treat #stroke | #roboticsurgery https://t.co/HBDihNDsal

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings